JPRN-UMIN000042729招募中未知
Safety and efficacy of switching from Aflibercept to Brolucizumab in patients with neovascular AMD - Safety and efficacy of switching from Aflibercept to Brolucizumab in patients with neovascular AMD
ational Hospital Organization Tokyo Medical Center0 个研究点目标入组 100 人开始时间: 2020年12月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Not applicable
研究者
相似试验
已完成
不适用
Investigation of clinical efficacy for Aflibercept in patients with polypoidal choroidal vasculopathy (PCV)Polypoidal Choroidal VasculopathyJPRN-UMIN000011091Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University50
进行中（未招募）
1 期
Switching to aflibercept in patients with wet AMD not responding to anti-VEGF treatment.eovascular Age-related macular degenerationEUCTR2013-001208-12-NLRadboud University Nijmegen Medical Centre20
已完成
4 期
Switching to aflibercept in patients with neovascular AMD not responding to anti-VEGF treatment.10047060macular degenerationage-related macular degenerationNL-OMON38763niversitair Medisch Centrum Sint Radboud20
招募中
不适用
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetes kidney diseasediabetic kidney disease, HyperuricemiaD033461, D003928HyperuricemiaJPRN-jRCTs031220080Osonoi Takeshi50
进行中（未招募）
1 期
Switch from Efavirenz / emtricitabine / tenofovir difumarate taken once a day or alternate day to Bictegravir / emtricitabine / tenofovir alafenamide in HIV+ patients with suppressed viral load.HIV infectionMedDRA version: 20.0Level: LLTClassification code 10020441Term: Human immunodeficiency virus infection, unspecifiedSystem Organ Class: 100000004862EUCTR2018-003880-79-ITISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI240